<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="336514">
  <stage>Registered</stage>
  <submitdate>9/02/2011</submitdate>
  <approvaldate>10/02/2011</approvaldate>
  <actrnumber>ACTRN12611000162910</actrnumber>
  <trial_identification>
    <studytitle>Vitamin C uptake from kiwifruit compared with a vitamin C supplement</studytitle>
    <scientifictitle>Vitamin C bioavailability from kiwifruit compared with a vitamin C supplement - a randomised parallel study in men</scientifictitle>
    <utrn>Nil</utrn>
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Vitamin C status</healthcondition>
    <conditioncode>
      <conditioncode1>Public Health</conditioncode1>
      <conditioncode2>Health promotion/education</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Arm 1 - baseline period (4 weeks) to monitor dietary intake of vitamin C; intervention period (6 weeks) - gold kiwifruit (half/day); washout period (4 weeks) to monitor return of plasma vitamin C to baseline levels. Arm 2 - baseline period (4 weeks) to monitor dietary intake of vitamin C; intervention period (6 weeks) - chewable vitamin C tablet  (45mg/day); washout period (4 weeks) to monitor return of plasma vitamin C to baseline levels. Arm 3 - baseline period (4 weeks) to monitor dietary intake of vitamin C; intervention period (6 weeks) - gold kiwifruit (two/day); washout period (4 weeks) to monitor return of plasma vitamin C to baseline levels.</interventions>
    <comparator>Arm 2 - vitamin C supplement</comparator>
    <control>Active</control>
    <interventioncode>Lifestyle</interventioncode>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Measurement of vitamin C status of blood plasma by HPLC</outcome>
      <timepoint>Weekly for 14-16 weeks</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Measurement of vitamin C status of white blood cells by HPLC</outcome>
      <timepoint>Before intervention and after intervention (6-8 weeks)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Measurement of vitamin C status of urine by HPLC</outcome>
      <timepoint>Before intervention and after intervention (6-8 weeks)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Measurement of vitamin C status of seminal fluid by HPLC</outcome>
      <timepoint>Before intervention and after intervention (6-8 weeks)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Measurement of vitamin C status of muscle biopsies by HPLC</outcome>
      <timepoint>Before intervention and after intervention (6-8 weeks)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Assessment of Profile of Mood States questionnaire</outcome>
      <timepoint>Before intervention and after intervention (6-8 weeks)</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Male aged 18-30 years
Non-smoker
Low/below average plasma vitamin C levels (&lt;40 uM)
Residing in Christchurch for the duration of the study</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>30</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Males</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Recent smoker (within previous year)
Allergy/intolerance to kiwifruit
Taking vitamin C containing supplements (within past three months)
Excessive alcohol consumption (&gt;21 standard drinks/week)
High fruit and vegetable consumption (&gt;5 servings/day)
Diabetes mellitus
Bleeding disorders
Obese (&gt;35 kg/m2)
Fear of needles</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Participants will be enrolled following screening for low vitamin C status
Allocation to intervention will be by sealed opaque envelopes</concealment>
    <sequence>Participants will be randomised via coin toss</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Bio-availability</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>13/06/2011</anticipatedstartdate>
    <actualstartdate>15/06/2011</actualstartdate>
    <anticipatedenddate />
    <actualenddate>26/07/2011</actualenddate>
    <samplesize>50</samplesize>
    <actualsamplesize>54</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>13/12/2011</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Canterbury</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Margreet Vissers</primarysponsorname>
    <primarysponsoraddress>University of Otago, Chirsthurch
2 Riccarton Ave
Christchurch 8140</primarysponsoraddress>
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Zespri International Ltd</fundingname>
      <fundingaddress>400 Maunganui Road
Mount Maunganui 3116</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Anitra Carr</sponsorname>
      <sponsoraddress>University of Otago, Chirsthurch
2 Riccarton Ave
Christchurch 8140</sponsoraddress>
      <sponsorcountry>New Zealand</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Vitamin C is an essential nutrient which is not produced in humans and consequently must be obtained through dietary sources.  Kiwifruit is an outstanding commonly available source of vitamin C, one serving providing about twice the recommended daily intake of the vitamin.  We are proposing to investigate the uptake of vitamin C from kiwifruit compared with a vitamin C supplement using a randomised parallel groups study design.  We will screen individuals for low vitamin C status and each participant will be randomised to receive either kiwifruit or a vitamin C supplement.  The vitamin C status of the participants blood plasma will be measured regularly as an indication of dietary intake of the vitamin.  Food and beverage records will also be filled out periodically to monitor the participants dietary intake of the vitamin.  The vitamin C levels of urine, semen, white blood cells and muscle tissue will be measured at the beginning and end of the supplementation period to determine cellular accumulation and excretion of the vitamin.  Overall, the proposed study will provide valuable information as to how the body accumulates and stores vitamin C, and whether or not a food source of the vitamin is preferred over a dietary supplement.</summary>
    <trialwebsite />
    <publication>Carr AC, Bozonet SM, Pullar JM, Simcock JW, Vissers MC. A randomized steady-state bioavailability study of synthetic versus natural (kiwifruit-derived) vitamin C. Nutrients. 2013 Sep 17;5(9):3684-95. 


Carr, A.C., Bozonet S.M., Pullar, J.M., Vissers, M.C.M. (2013). Mood improvement in young adult males following supplementation with gold kiwifruit, a high vitamin C food. J Nutr Sci. 2 (e24), 1-8. doi:10.1017/jns.2013.12.


Carr, A.C., Bozonet S.M., Pullar, J.M., Simcock, J.W., Vissers, M.C.M. (2013). Human skeletal muscle ascorbate is highly responsive to changes in vitamin C intake and plasma concentrations. Am J Clin Nutr. 97 (4), 800-807.
</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Upper South Regional Ethics Committee</ethicname>
      <ethicaddress>250 Oxford Terrace 
Christchurch 8011</ethicaddress>
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate>7/02/2011</ethicsubmitdate>
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Prof</title>
      <name>Margreet Vissers</name>
      <address>University of Otago, Christchurch
2 Riccarton Ave
Christchurch 8140</address>
      <phone>64 3 364 1524</phone>
      <fax />
      <email>margreet.vissers@otago.ac.nz</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Anitra Carr</name>
      <address>University of Otago, Christchurch
2 Riccarton Ave
Christchurch 8140</address>
      <phone>64 3 378 6498</phone>
      <fax />
      <email>anitra.carr@otago.ac.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Anitra Carr</name>
      <address>University of Otago, Christchurch
2 Riccarton Ave
Christchurch 8140</address>
      <phone>64 3 378 6498</phone>
      <fax />
      <email>anitra.carr@otago.ac.nz</email>
      <country>New Zealand</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Margreet Vissers </name>
      <address>University of Otago, Christchurch 2 Riccarton Ave Christchurch 8140 </address>
      <phone>64 3 364 1524  </phone>
      <fax />
      <email>margreet.vissers@otago.ac.nz  </email>
      <country>New Zealand</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>